Search results
What Makes Amarin (AMRN) a New Buy Stock
Zacks via Yahoo Finance· 5 months agoAmarin (AMRN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock...
Amarin (AMRN) Stock Rises on Stellar Q4 Preliminary Results
Zacks via Yahoo Finance· 4 months agoAmarin (AMRN) issues encouraging preliminary results for the fourth quarter and full-year 2023. The...
Are Medical Stocks Lagging Amarin (AMRN) This Year?
Zacks via Yahoo Finance· 3 months agoInvestors interested in Medical stocks should always be looking to find the best-performing companies in the group. Amarin (AMRN) is a stock that can...
Amarin (AMRN) Q2 Earnings and Revenues Surpass Estimates
Zacks via Yahoo Finance· 9 months agoAmarin Corporation Plc AMRN reported second-quarter 2023 adjusted earnings of 2 cents per share,...
Amarin (AMRN) Q2 Earnings & Sales Hurt by Vazkepa Generics
Zacks via Yahoo Finance· 2 years agoAmarin's (AMRN) Vazkepa sales decline year over year amid rising generic competition and...
Amarin (NASDAQ:AMRN) shareholders have endured a 83% loss from investing in the stock three years...
Simply Wall St. via Yahoo Finance· 10 months agoIt's not possible to invest over long periods without making some bad investments. But really bad...
Amarin Plc (AMRN) Q4 2023 Earnings Call Transcript
Motley Fool via Yahoo Finance· 2 months agoImage source: The Motley Fool. Amarin Plc (NASDAQ: AMRN) Q4 2023 Earnings Call Feb 29, 2024, 8:00 a.m. ET Contents: Prepared Remarks Questions and...
Are Investors Undervaluing Amarin Corporation plc (NASDAQ:AMRN) By 27%?
Simply Wall St. via Yahoo Finance· 6 months agoKey Insights The projected fair value for Amarin is US$0.95 based on 2 Stage Free Cash Flow to...
Amarin (AMRN) Dips 16% on Layoff Plan & Preliminary Sales Miss
Zacks via Yahoo Finance· 9 months agoAmarin (AMRN) decides to initiate a restructuring plan to maximize cash flow opportunities in the...
Amarin (AMRN) Up 7% on Intellectual Property Wins in Europe
Zacks via Yahoo Finance· 3 weeks agoAmarin (AMRN) secures a new patent for Vazkepa in Europe, which extends its exclusivity for eight...
